Thomas Blaettler
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Thomas Blaettler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
39
| Subsidiary | Pharmaceuticals: Major | 39 |
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Blaettler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PRUDENTIAL PLC | Life/Health Insurance | Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| UBS | Investment Managers | Director/Board Member Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMYRIS, INC. | Chemicals: Specialty | Director/Board Member Chairman | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree | |
| RAMSAY HEALTH CARE LIMITED | Hospital/Nursing Management | Director/Board Member | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Graduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Doctorate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Bern | College/University | Doctorate Degree Undergraduate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Mckinsey & Co. (China) | Corporate Officer/Principal | ||
| St. Gallen Foundation for International Studies | Director/Board Member | ||
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
Calico LLC
 Calico LLC BiotechnologyHealth Technology Part of Alphabet, Inc., Calico LLC conducts research into the biology of aging. The company is based in South San Francisco, CA. Arthur D. Levinson has been the CEO of the company since 2013. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Investment Managers | Consultant / Advisor | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Huma Therapeutics Ltd.
 Huma Therapeutics Ltd. Packaged SoftwareTechnology Services Huma Therapeutics Ltd. engages in the provision of enterprise imaging solutions, cancer, cardiovascular and diabetes applications. It offers digital biomakers and therapeutics, and remote patient monitoring. The company was founded by Rich Khatib and Danoosh Vahdat in 2011 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| St. Galler Stiftung für Internationale Studien | Investment Trusts/Mutual Funds | Director/Board Member | |
| Cyrcadia Ltd. | Director/Board Member | ||
| Edugreen Education & Services Ltd. | Director/Board Member | ||
| Buurtzorg Neighborhood Care Asia Ltd. | Director/Board Member | ||
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 18 |
| Schweiz | 12 |
| Niederlande | 6 |
| Vereinigtes Königreich | 5 |
| Dänemark | 3 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 278 |
| Corporate Officer/Principal | 142 |
| Independent Dir/Board Member | 73 |
| Chairman | 47 |
| Chief Tech/Sci/R&D Officer | 39 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Martijn Kleijwegt | 33 |
| Luba Greenwood | 32 |
| Anders Hedegaard | 30 |
| Rémi Droller | 29 |
| Catherine Moukheibir | 29 |
| Patrick Yang | 28 |
| William Burns | 27 |
| Claudia Dyckerhoff | 26 |
| Roland Diggelmann | 22 |
| Zafrira Avnur | 20 |
| Arthur Levinson | 19 |
| Alexander Mayweg | 18 |
| Hyam Levitsky | 18 |
| Karen Wagner | 17 |
| Hal Barron | 16 |
- Börse
- Insiders
- Thomas Blaettler
- Unternehmensverbindungen
